{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:095c7977-676f-4dab-977b-650f007f6cf9", "type": "text", "profile": "update", "version": "1", "versioncreated": "2026-10-06T16:05:00.857546Z", "firstcreated": "2026-10-06T16:01:49.207716Z", "pubstatus": "usable", "urgency": 5, "language": "ru", "headline": "Минздрав зарегистрировал «Элефузу» для терапии рака яичников и груди", "byline": "Вера Ершова", "located": "RU", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Пладром", "usageterms": "Monitoring item. Headline, short extract and the source link may be shown. Do not republish the full text.", "description_text": "Минздрав России зарегистрировал препарат «Элефуза» (фузулопариб) для лечения распространенного эпителиального рака яичников, рака маточной трубы, первичного перитонеального рака и метастатического HER2-негативного рака молочной железы у пациенток с мутациями BRCA1/2. Молекулу разработала китайская Jiangsu Hengrui Pharmaceuticals, а поставлять препарат на российский рынок будет «Петровакс Фарм».", "altids": {"mosaic": "095c7977-676f-4dab-977b-650f007f6cf9", "story": "ed5e4df3-9b48-468b-9c27-28d9ffe36600", "slug": "minzdrav-zaregistriroval-elefuzu-dlia-terapii-raka-iaichnikov-i-grudi"}, "subject": [{"name": "Science", "rel": "direct", "literal": "science", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "RU", "literal": "ru", "code": "RU", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Updated story", "literal": "update"}], "service": [{"name": "Wireva", "literal": "wireva"}], "body_text": "Минздрав России зарегистрировал препарат «Элефуза» (фузулопариб) для лечения распространенного эпителиального рака яичников, рака маточной трубы, первичного перитонеального рака и метастатического HER2-негативного рака молочной железы у пациенток с мутациями BRCA1/2. Молекулу раз", "extra_body_note": "Extract only — see rights.class = link_only.", "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:88c40213-8e7f-4b21-af45-50d1c8602698", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "В России зарегистрировали новый препарат для лечения рака яичников и груди. Его разработала китайская компания — The Insider", "description_text": "Минздрав зарегистрировал «Элефузу» для терапии рака яичников и груди", "copyrightholder": "theins.ru", "copyrightnotice": "В России зарегистрировали новый препарат для лечения рака яичников и груди. Его разработала китайская компания — The Insider", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "88c40213-8e7f-4b21-af45-50d1c8602698"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "RSS source", "licence_verified_at": "2026-10-06T16:05:00.881837Z", "attribution_required": true, "attribution_text": "В России зарегистрировали новый препарат для лечения рака яичников и груди. Его разработала китайская компания — The Insider", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "theins.ru", "source_url": "https://theins.ru/storage/post_cover/original/297/297951/89TB9j3ey5UGSEScXwAiXAeSERDDIOZetqnzXmN6.jpg", "source_page_url": "https://theins.ru/storage/post_cover/original/297/297951/89TB9j3ey5UGSEScXwAiXAeSERDDIOZetqnzXmN6.jpg", "our_page_url": "https://pladrom.com/nauka/minzdrav-zaregistriroval-elefuzu-dlia-terapii-raka-iaichnikov-i-grudi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://theins.ru/storage/post_cover/original/297/297951/89TB9j3ey5UGSEScXwAiXAeSERDDIOZetqnzXmN6.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:ed5e4df3-9b48-468b-9c27-28d9ffe36600", "slug": "story-20261006-25", "status": "updated", "languages": ["ru"], "item_count": 5, "is_breaking": false}, "wireva:rights": {"class": "link_only", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Пладром", "canonical_required": true, "canonical_url": "https://pladrom.com/nauka/minzdrav-zaregistriroval-elefuzu-dlia-terapii-raka-iaichnikov-i-grudi/", "linkback_required": true, "licence": "", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 280, "decided_by_rule": "derivation_failed", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {"editing": true, "drafting": true, "headline": true, "discovery": true, "classification": true, "image_selection": true, "source_collection": true, "cross_source_comparison": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "failed", "score": 0.957, "checked_at": "2026-10-06T16:05:00.878250Z"}}, "wireva:publication": {"name": "Пладром", "domain": "pladrom.com", "country": "RU", "url": "https://pladrom.com/nauka/minzdrav-zaregistriroval-elefuzu-dlia-terapii-raka-iaichnikov-i-grudi/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/095c7977-676f-4dab-977b-650f007f6cf9", "html": "https://wireva.mib.news/item/095c7977-676f-4dab-977b-650f007f6cf9/minzdrav-zaregistriroval-elefuzu-dlia-terapii-raka-iaichnikov-i-grudi/", "story": "https://wireva.mib.news/story/story-20261006-25/"}, "wireva:metrics": {"word_count": 560, "char_count": 4461, "reading_time_seconds": 319}}}